Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

Go back to Viking Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Tops Q4 EPS by 3c

February 9, 2022 4:15 PM EST

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

... More